Photoacoustic molecular imaging of angiogenesis using theranostic α_νβ_3-targeted copper nanoparticles incorporating a sn-2 lipase-labile fumagillin prodrug by Zhang, Ruiying et al.
PROCEEDINGS OF SPIE
SPIEDigitalLibrary.org/conference-proceedings-of-spie
Photoacoustic molecular imaging of
angiogenesis using theranostic ανβ3-
targeted copper nanoparticles
incorporating a sn-2 lipase-labile
fumagillin prodrug
Ruiying  Zhang, Xin  Cai, Xiaoxia  Yang, Angana  Senpan,
John S. Allen, et al.
Ruiying  Zhang, Xin  Cai, Xiaoxia  Yang, Angana  Senpan, John S. Allen,
Dipanjan  Pan, Gregory M. Lanza, Lihong V. Wang, "Photoacoustic molecular
imaging of angiogenesis using theranostic ανβ3-targeted copper
nanoparticles incorporating a sn-2 lipase-labile fumagillin prodrug," Proc.
SPIE 8943, Photons Plus Ultrasound: Imaging and Sensing 2014, 89435I (3
March 2014); doi: 10.1117/12.2041120
Event: SPIE BiOS, 2014, San Francisco, California, United States
Downloaded From: https://www.spiedigitallibrary.org/conference-proceedings-of-spie on 9/4/2018  Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
  
Photoacoustic molecular imaging of angiogenesis using theranostic 
ανβ3-targeted copper nanoparticles incorporating a sn-2 lipase-labile 
fumagillin prodrug  
Ruiying Zhang
a
 , Xin Cai
a
, Xiaoxia Yang
b
, Angana Senpan
b
, John S. Allen
b
, Dipanjan Pan
c
 ,Gregory 
M. Lanza
b
 and Lihong V. Wang
a*
 
  a
Optical Imaging Laboratory, Department of Biomedical Engineering, Washington University in St. 
Louis, St. Louis, MO USA 63130; 
b
Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO 
USA 63108; 
c
Department of Bioengineering, University of Illinois at Urbana-Champaign, Champaign, IL USA, 
61801 
ABSTRACT  
Photoacoustic (PA) tomography imaging is an emerging, versatile, and noninvasive imaging modality, which combines 
the advantages of both optical imaging and ultrasound imaging. It opens up opportunities for noninvasive imaging of 
angiogenesis, a feature of skin pathologies including cancers and psoriasis. In this study, high-density copper oleate 
encapsulated within a phospholipid surfactant (CuNPs) generated a soft nanoparticle with PA contrast comparable to 
gold.  Within the near-infrared window, the copper nanoparticles can provide a signal more than 7 times higher that of 
blood. ανβ3-integrin targeting of CuNPs in a Matrigel mouse model demonstrated prominent PA contrast enhancement of 
the neovasculature compared to mice given nontargeted or competitively inhibited CuNPs. Incorporation of a sn-2 
lipase-labile fumagillin prodrug into the CuNPs produced marked antiangiogenesis in the same model, demonstrating the 
theranostic potential of a PA agent for the first time in vivo. With a PA signal comparable to gold-based nanoparticles 
yet a lower cost and demonstrated drug delivery potential, ανβ3-targeted CuNPs hold great promise for the management 
of skin pathologies with neovascular features. 
Keywords: Copper nanoparticles, ανβ3-targeted, photoacoustic molecular imaging, angiogenesis, antiangiogenic 
therapy, fumagillin prodrug 
 
1. INTRODUCTION  
Photoacoustic (PA) imaging, combining the advantage of ultrasound imaging and optical imaging, has attracted much 
attention. Based on the detection of optical absorbers such as hemoglobin, it offers high depth-to-resolution with 
different scales, ranging from organelles to organs. Previous studies have confirmed the potential of PA imaging with 
exogenous contrast agents to quantify vascularization, oxygen saturation and angiogenesis. 
1-6
 For example, gold 
nanoparticles, with their large absorption cross section, can be tuned to the optical window, which minimizes 
endogenous absorption and maximizes imaging depth. The conjugation capability of nanoparticles enables biomarker 
targeting for molecular imaging and drug delivery. 
7 
However, because of the high cost of gold nanoparticles, their clinical use is discouraged. Furthermore, manufacturing 
them requires complicated morphology and expensive chemistries. An alternative low-cost contrast agent is desirable, 
but has not been reported yet. In this paper, we hypothesize a new kind of vascular-constrained, ανβ3-targeted copper 
nanoparticles (CuNPs) for the discrimination of neovasculature. As copper is cheaper than gold, these nanoparticles are 
expected to provide an inexpensive and effective alternative optical contrast agent for PA imaging. In this work, the PA 
imaging was performed with our home-made PA deep imaging system. The data and images from different groups of 
mice after the injection of copper nanoparticles were compared and analyzed. 
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2. METHODS 
2.1 Synthesis of nanoparticles  
The synthesis of copper nanoparticles was performed similarly to the synthesis of gold nanoparticles reported 
8
, except 
that the Cu-oleate was immersed in almond oil instead of octanethiol-coated gold nanoparticles. Fumagilin (1 mol %) 
was incorporated into the lipid layer of the CuNPs as shown in Fig. 1. 
 
Fig. 1 Schematic of the copper nanoparticles incorporating fumagillin 
2.2 Matrigel model of angiogenesis 
Athymic nude-mice with body weights ranging from 23 to 27 g were used. The anesthesia induction utilized ketamine 
(100 mg/ml) and xylazine (20 mg/ml) that was maintained with 0.5% -1% isoflurane in oxygen on a ventilator. Matrigel 
(0.5 ml, BI; Biosciences, San Jose, CA, USA) enriched with fibroblast growth factor -2 (500 nm/ml; Sigma-Aldrich, St. 
Louis, MO, USA) and heparin was implanted subcutaneously along the flank. The nude mice (N = 15) were randomly 
distributed into four groups and injected with: 1) ανβ3 CuNPs w/o fumagilin (N = 3) right before PA imaging;  2) 
ανβ3/fumagilin CuNPs (N = 3) on day 11 and day 15 as antiangiogenesis therapy, and ανβ3 CuNPs w/o fumagilin (N = 3) 
right before PA imaging; 3) ανβ3 blank particles and 10 mins later, treated with ανβ3 CuNPs w/o fumagilin (N = 3) right 
before PA imaging; 4) non-targeted CuNPs right before PA imaging. PA imaging was performed before the injection, 
and serially over 3~5 h post-injection on day 17-19. Animal studies were performed under a protocol approved by 
Washington University Medical School Animal Studies Committee. 
2.3 PA imaging system 
Using dark-field ring-shaped illumination, a reflection-mode PA imaging system
9
 was pumped by a Q- switched 
Nd:YAG (LS-2137; Lotis TII) laser with  <15-ns pulse duration and a 10-Hz pulse repetition rate. The light energy on 
the sample surface was controlled to conform to the American National Standards Institute standard for maximum 
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permissible exposure. A 10 MHz central frequency, spherically focused (2.54-cm focus length, 1.91-cm diameter active 
area element, and 72% bandwidth) ultrasonic transducer (V308; Panametrics-NDT, Waltham, MA, USA) was used to 
acquire the generated PA signals. The signal was amplified by a low-noise amplifier (5072PR; Panametrics-NDT), and 
recorded using a digital oscilloscope (TDS 5054; Tektronix, Beaverton, OR, USA) with 50-MHz sampling. PA signal 
fluctuations due to pulse-to-pulse energy variation were compensated for by signals from a photodiode (DET110; 
Thorlabs, Newton, NJ, USA), which sampled the energy of each laser pulse. A linear translation stage (XY-6060; 
Danaher Motion, Rad- ford, VA, USA) was used for raster scanning to obtain 3-D PA data. A computer controlled the 
stage and synchronized it with the data acquisition. To shorten the data acquisition time, a continuous scan was used 
without signal averaging. Typical scanning values are as follows: voxel dimension, 0.1 × 0.2 mm; laser pulse repetition 
rate, 10 Hz; acquisition time, ~20 min. In vivo imaging was performed using ventilated anesthetized mice with shaved 
flanks, constantly warmed to 37°C by a heating block and positioned immediately beneath the transparent clear 
membrane. The resolution of the system using a 10 MHz transducer was tested prior to imaging. It was shown that at the 
focus, the resolution was around 137 μm. 
An angiogenesis index, defined as the cross-product of blood vessel pixel number and the total PA signal from those 
pixels, was used to quantify the visualization of angiogenesis. The angiogenesis index was normalized to that of the 
pretreatment during the analysis. 
3. RESULTS 
The efficacy of CuNPs was compared with blood in the near-infrared (NIR) window. The PA signal was obtained from 
fresh bovine blood (Quad Five, Cat. #905, Hct., 30%~ 50%) and CuNPs (2 wt/vol%) filled in a tygon tube (i.d. = 
510μm) at laser wavelength from 725 nm to 830 nm. Fig. 2(a) and (b) show that the PA signal from CuNPs was clearly 
much stronger than that from blood over the entire spectrum. Also, when the laser is tuned to 770 nm, the PA signal of 
the CuNPs reaches its peak. Considering the ratio of PA signal and laser energy at different wavelengths, 770 nm was 
chosen. Shown in Fig. 2(c), at 770 nm, the peak-to-peak PA signal amplitude obtained from CuNPs was ~2.5 V, 
compared to ~0.32 V peak-to-peak PA signal from blood alone, which is about 7 times stronger than that from blood at 
770 nm wavelength. The typical preparation of CuNPs (2 wt/vol%) provided an SNR of 36 dB at 770 nm in vitro. The 
high ratio of PA signal amplitude derived from CuNPs over blood suggests potential clinical use for intravascular and 
extravascular applications within the NIR window.  
 
Fig.2  (a) Comparative PA spectra of  CuNPs and blood over 730-830 nm NIR wavelength range. (b) Ratio of the peak-to-
peak PA signal amplitudes generated from CuNPs to those of blood over 730-830 nm. (c)PA spectroscopy signals generated 
from a tygon tube (i.d. = 510 μm) filled with  CuNPs. The laser was tuned to 770 nm wavelength The results were obtained 
using deep PA system without calibration of laser energy under different wavelength. 
A time course study revealed gradual signal enhancement with ανβ3-targeted CuNPs post-treatment in a mouse Matrigel-
plug model, at every 0.5 h interval up to 3.5 h. A nude mouse bearing 17-d implant was treated intravenously with ανβ3-
targeted CuNPs. The PA signal changes in the Matrigel plug area after the injection of ανβ3-targeted CuNPs were 
monitored serially over 3.5 h. (Fig. 3). Signals from individual vessels were enhanced with time. Neovessels and 
angiogenic sprouts, which cannot be visualized with hemoglobin alone, were observed. It can be concluded that as time 
increases, ανβ3-targeted CuNPs penetrate into the Matrigel plug and target angiogenic vessels. Some angiogenic vessels 
seen in the Matrigel plug were still under development, which would make them below the resolution of PA. Fig.3 (e) 
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illustrates an overall signal enhancement of all the vessels in the Matrigel plug area, suggesting all the vessels in the 
image may be angiogenic vessels.  
 
Fig.3 After 17d bearing Matrigel plug (0.5 ml), a nude mouse was imaged by PA. (a) PA maximum amplitude       projection 
(MAP) image of the area with Matrigel plug. This is a control image. (b) - (e)  A time course study was conducted after the 
injection of targeted CuNPs. PA images were taken every 0.5 h up to 3.5 h. For all PA images, PA wavelength = 770 nm 
and scale bar = 2 mm, field of view, 14 ×17 mm. 
The effectiveness of fumagillin therapy was proved by a time course study with PA, shown in Fig. 4. Signals from the 
Matrigel plug area after the fumagillin therapy were monitored over 4 h. Fewer vessels can be visualized both before and 
after the injection of ανβ3-targeted CuNPs compared with those in Fig. 3. Also, both the number and the signal amplitude 
of vessels in the PA image stayed the same after the injection. These results suggest that the fumagillin therapy with 
ανβ3-targeted CuNPs successfully suppressed the level of neovasculature.  
 
Fig. 4. After 17 d bearing Matrigel plug and undergoing fumagillin therapy, the nude mouse was imaged by PA. (a) PA 
maximum amplitude projection (MAP) image of the area of Matrigel plug. This is a control image. (b) PA MAP image 
taken at 4 h after the injection of CuNPs. For all PA images, PA wavelength = 770 nm and scale bar = 2 mm, field of view, 
10 ×10 mm 
The aniogenesis index was calculated to quantify the PA image change between different groups. Fig. 5 shows the 
angiogenesis curve versus time: angiogenesis index increased with time for ανβ3-targted CuNPs group but almost 
remains unchanged or changed little for the other three groups.  
4. DISCUSSIONS 
As an essential biomarker of tumors and progression of cardiovascular disease, angiogenesis provides us with 
information about disease progression and intensity
10
. Photoacoustic (PA) imaging, which closes the resolution limit of 
in vitro microscopic methods and existing clinical methods, has the potential inexpensively, and in a versatile way, to 
visualize and quantify the angiogeneic status of cardiovascular disease and tumors. The results of our present study 
indicate that PA imaging with the proposed low-cost ανβ3-targeted CuNPs can be applied to angiogenesis imaging in 
vivo. According to PA images acquired every 30 mins after the injection of CuNPs, an increasing number of angiogenic 
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sprouts and bridges between the mature vessels became visible as PA signals were enhanced within these vessels. This 
result was supported by an increasing value of the angiogenesis index, which is an indicator of the intensity of 
angiogenesis. The successful amplification of the PA signal after treatment requires binding of endothelial ανβ3-integrin 
receptors, which are sparsely distributed on the luminal aspect of quiescent endothelial cells
6
, precluding the interactive 
binding of CuNPs to nonendothelial cells. The high specificity and binding affinity of this homing ligand is the key to 
the success.  
 
Fig. 5 Angiogenesis index versus time for four groups of mice. 
PA imaging with contrast agents, such as dyes, gold nanoparticles, nanorods or nanocages has been reported previously. 
But these agents can diffuse out of neovessels easily and bind to numerous cell types (other than endothelial cells) with 
ανβ3-integrin. In contrast, the CuNPs in the present study can avoid such a “leaky” behavior and stay constrained within 
the Matrigel plug area, which is essential for quantitative purposes in a clinical study. The present study, to the best of 
our knowledge, is the first demonstration of PA imaging with CuNPs. With the inexpensive manufacturing, compared to 
the unpredictable and high cost of the existing gold nanoparticles, CuNPs have great potential for clinical use. However, 
it should also be noted that, there is still a long way to go before the clinical translation of CuNPs, considering the 
availability of clinical photoacoustic tomography scanners and the time required for investigational new drug approval. 
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